Patent №
US 6,974,791
Granted
2005-12-13
Filed 2001
Owner
PITTSBURGH, UNIVERSITY OF
Lab
—
AI components
1
vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
09810700
Peptide motifs which define specificity of tumor-derived endothelial cells. These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium. The specific molecular peptide motifs will facilitate diverse therapeutic and diagnostic applications including: anti-angiogenic therapies to be used in alone or in conjunction with standard therapies; imaging tools for both detection of very small metastasis that are undetectable by current techniques; for monitoring tumor response; for targeting and directing chemotherapy drugs to the tumor; for treatment of chronic inflammatory diseases such as rheumatoid arthritis and psoriasis, for treating some forms of blindness; as well as other diagnostic and therapeutic applications.
AI classification
Ownership
PITTSBURGH, UNIVERSITY OF
assignment · 122810987
Assignors
WONG, MICHAEL K., MODZELEWSKI, RUTH A., BROWN, CHARLES KOMEN, JOHNSON, CANDACE S., TRUMP, DONALD J.
On an employer assignment, the assignors are typically the inventors.